Q2 Begins on the Back foot Q2 Begins on the Back foot Q2 Begins on the Back foot

Q2 Begins on the Back foot

Summary:  With the slate cleared of month/quarter end flows and pension fund rebalancing, Asia equity markets begin mixed.


At the time of writing, ASX 200 +1.71%, Nikkei 225 -1.14%, KOSPI +0.40% and US futures heading lower on light volumes in the Asia session.

This after declines across the board on Wall Street as stocks slumped into the Q1 finish line. The S&P 500’s 38.2% Fibonacci retracement at 2650.89 is proving a tough nut to crack with the bear market rally meeting some temporary resistance around this level. The quarter finishing on a dour note, now the S&P 500's worst quarter since 2008 and the DJIA's worst quarter since 1987, with the month of March being the most volatile month ever for the S&P 500.

Source: Bespoke Invest

Following overnight declines, stocks began trading cautiously in the Asia session and the White House coronavirus briefing added fuel to that fire. Taking the positives, the good news is the administration are no longer hoping for an Easter resumption and have heeded the advice of medical professionals with respect to containment measures in the attempt to flatten the COVID-19 infection curve. However, unfortunately, we are still in the early stages of the infection cycle in the US and the briefing confirmed this notion. Clearly, examining modelling estimates and they are just that (estimates), relative to the current death toll of almost 4000 vs. the models projections of 100,000 – 240,000 it is unlikely that we have seen the worst in the US yet. President Trump corroborating this, warning that the country faces a “painful two weeks” ahead.

A host of Asia manufacturing PMI’s released today have done little to buoy sentiment, as they illustrate the abrupt slump in economic activity, deteriorating employment outlook and declining forward outlook as lockdowns are ramped up and in some cases extended. Asia’s factory outlook has not only suffered the extent of China’s lockdown but is now being dealt a second wave of headwinds as demand from Europe and the US collapses.

  • Jibun Bank Japan March Manufacturing PMI 44.8 vs 47.8 in Feb.
  • Markit South Korea March Manufacturing PMI 44.2 vs 48.7 in Feb.
  • Markit Taiwan March Manufacturing PMI 50.4 vs 49.9 in Feb.
  • Markit Thai March Manufacturing PMI 46.7 vs 49.5 in Feb.
  • Markit Indonesia March Manufacturing PMI 45.3 vs 51.9 in Feb.
  • Markit Vietnam March Manufacturing PMI 41.9 vs 49 in Feb.
  • Markit Malaysia March Manufacturing PMI 48.4 vs 48.5 in Feb.
  • Markit Philippines March Manufacturing PMI 39.7 vs 52.3 in Feb.
  • Markit Myanmar March Manufacturing PMI 45.3 vs 49.8 in Feb.

The exception, the Australian AIG manufacturing PMI, which rebounded back to expansionary levels. However, before getting too excited, the accompanying analysis from AI Group poured cold water on the rebound, stating the result was "almost entirely due to a huge surge in demand for...food, toilet paper, cleaning products and other household essentials". So a direct result of the fear induced panic buying and hoarding from Australian consumers.

Also a dampener in the Asia session the news that both Standard Chartered and HSBC will suspend dividend payments. This pressuring the Hang Seng lower. Reminding investors that in the current environment for some companies, elevated dividend yields will not be sustainable and investors should maintain a highly selective approach when picking high yielding stocks for their portfolios. Over the coming months as company earnings are pressured, many dividend payments will be suspended or cut. This as company balance sheets are hit by the simultaneous demand and supply shock the COVID-19 crisis brings. And in this scenario companies value a strong balance sheet over maintaining payout ratios. It will be more important to maintain liquidity and stay solvent whilst revenues and operating incomes are hit. Another factor at play with respect to reduced dividends, the impending regulatory pressure emerging as governments globally weigh suspending the payment of dividends, and company buybacks for those companies seeking bailouts. Why privatise gains, but socialise losses for taxpayer to bear the brunt.

Another story to watch, with China being the first country to come through the peak of the COVID-19 crisis, and the first to stabilise the contagion, there will be important notes to be gleaned from the post COVID-19 picture. How quickly the economy is able to resume normal activity levels and the toll the virus outbreak takes on consumers will likely offer clarity to the trends we can expect to see emerging in Europe and the US post lockdown. As we noted last week, there are signs of weakness in China’s consumer credit market which could become the reality in the US and Europe over the coming months as the jump in unemployment cascades into consumer credit market. As Bloomberg notes a worrying trend is emerging with respect to consumer behaviour, even as lockdowns are lifted consumers are reluctant to head out and many are still concerned about their financial situation which will likely keep pressure on the marginal propensity to spend. This sort of lasting shock to consumer activity and sentiment will clog the transmission of fiscal stimulus measures as fearful consumers pocket cash and save in favour of spending.

Disclaimer

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-hk/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-hk/about-us/awards.

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.